Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of JTE-051 Administered for 12 Weeks in Subjects With Moderate to Severe Plaque Psoriasis (CLEAR-PS)
Conditions
Interventions
JTE-051
Placebo
Locations
16
United States
First OC Dermatology
Fountain Valley, California, United States
Center For Dermatology Clinical Research, Inc.
Fremont, California, United States
University of South Florida - Hospital
Tampa, Florida, United States
Atlanta Dermatology Vein and Research Center LLC
Alpharetta, Georgia, United States
Advanced Medical Research, PC
Sandy Springs, Georgia, United States
Advanced Clinical Research - Dermatology Center of Canyon County
Nampa, Idaho, United States
Start Date
November 10, 2017
Primary Completion Date
October 29, 2018
Completion Date
October 29, 2018
Last Updated
August 6, 2021
NCT07474792
NCT00344188
NCT06979453
NCT07116967
NCT07250802
NCT07449702
Lead Sponsor
Akros Pharma Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions